The company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
Xianle Health Technology Co., Ltd. (hereinafter referred to as the "Company") held the 21st meeting of the Fourth Board of Directors on April 22, 2026. The meeting deliberated and passed the "Proposal on Amending the Company's Business Scope and Articles of Association, and the Draft Articles of Association Applicable to the H-Share Offering and Listing." The Company intends to amend its business scope and its Articles of Association, as well as the Draft Articles of Association applicable to the H-Share Offering and Listing. This proposal is subject to the approval of the Company's shareholders' meeting. The relevant situation is hereby announced as follows:
I. Changes to the Company's Business Scope
Based on the Company's actual operating conditions, the Company proposes to amend its business scope as follows: